APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chitosan Hemostatic Material

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Chitosan Hemostatic Material Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025196 pages

Choose your research edition.

Industry ResearchChitosan Hemostatic Material Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Chitosan Hemostatic Material Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Chitosan Hemostatic Material Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chitosan Hemostatic Material Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Chitosan Hemostatic Material Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Chitosan Hemostatic Material market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Chitosan Hemostatic Material is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chitosan Hemostatic Material is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chitosan Hemostatic Material is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chitosan Hemostatic Material is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chitosan Hemostatic Material include Lanhine Medical, Yancheng Yankang Medical Equipment, Shijiazhuang Yishengtang Medical Product, Success Bio-Tech, Biotemed, Haiyuan Hairun, Tricol Biomedical, Mermaid Medical and MedTrade Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chitosan Hemostatic Material market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chitosan Hemostatic Material and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chitosan Hemostatic Material sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chitosan Hemostatic Material market size, projected growth trends, production technologies, key applications, and end-use industries.

Chitosan Hemostatic Material Segment by Company

Lanhine Medical

Yancheng Yankang Medical Equipment

Shijiazhuang Yishengtang Medical Product

Success Bio-Tech

Biotemed

Haiyuan Hairun

Tricol Biomedical

Mermaid Medical

MedTrade Products

Medcura

Hemostasis

Hemoflex

BioPharm Med

Anscare

Advamedica

Chitosan Hemostatic Material Segment by Type

Hemostatic Powder

Hemostatic Sponge

Hemostatic Gauze

Others

Chitosan Hemostatic Material Segment by Application

Surgery

First Aid

Chitosan Hemostatic Material Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chitosan Hemostatic Material market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chitosan Hemostatic Material and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chitosan Hemostatic Material.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chitosan Hemostatic Material market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chitosan Hemostatic Material manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Chitosan Hemostatic Material in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Chitosan Hemostatic Material in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Chitosan Hemostatic Material Industry Trends Table 2. Chitosan Hemostatic Material Industry Drivers Table 3. Chitosan Hemostatic Material Industry Opportunities and Challenges Table 4. Chitosan Hemostatic Material Industry Restraints Table 5. Global Chitosan Hemostatic Material Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Chitosan Hemostatic Material Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Chitosan Hemostatic Material Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Chitosan Hemostatic Material Sales Market Share by Manufacturers Table 9. Global Chitosan Hemostatic Material Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Chitosan Hemostatic Material Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Chitosan Hemostatic Material Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Chitosan Hemostatic Material Manufacturers, Product Type & Application Table 13. Global Chitosan Hemostatic Material Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Chitosan Hemostatic Material by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hemostatic Powder Table 17. Major Manufacturers of Hemostatic Sponge Table 18. Major Manufacturers of Hemostatic Gauze Table 19. Major Manufacturers of Others Table 20. Global Chitosan Hemostatic Material Sales by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Chitosan Hemostatic Material Sales by Type (2021-2026) & (Units) Table 22. Global Chitosan Hemostatic Material Sales by Type (2027-2032) & (Units) Table 23. Global Chitosan Hemostatic Material Sales Market Share by Type (2021-2026) Table 24. Global Chitosan Hemostatic Material Sales Market Share by Type (2027-2032) Table 25. Global Chitosan Hemostatic Material Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 26. Global Chitosan Hemostatic Material Revenue by Type (2021-2026) & (Units) Table 27. Global Chitosan Hemostatic Material Revenue by Type (2027-2032) & (Units) Table 28. Global Chitosan Hemostatic Material Revenue Market Share by Type (2021-2026) Table 29. Global Chitosan Hemostatic Material Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Surgery Table 31. Major Manufacturers of First Aid Table 32. Global Chitosan Hemostatic Material Sales by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Chitosan Hemostatic Material Sales by Application (2021-2026) & (Units) Table 34. Global Chitosan Hemostatic Material Sales by Application (2027-2032) & (Units) Table 35. Global Chitosan Hemostatic Material Sales Market Share by Application (2021-2026) Table 36. Global Chitosan Hemostatic Material Sales Market Share by Application (2027-2032) Table 37. Global Chitosan Hemostatic Material Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 38. Global Chitosan Hemostatic Material Revenue by Application (2021-2026) & (Units) Table 39. Global Chitosan Hemostatic Material Revenue by Application (2027-2032) & (Units) Table 40. Global Chitosan Hemostatic Material Revenue Market Share by Application (2021-2026) Table 41. Global Chitosan Hemostatic Material Revenue Market Share by Application (2027-2032) Table 42. Global Chitosan Hemostatic Material Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Chitosan Hemostatic Material Sales by Region (2021-2026) & (Units) Table 44. Global Chitosan Hemostatic Material Sales Market Share by Region (2021-2026) Table 45. Global Chitosan Hemostatic Material Sales Forecasted by Region (2027-2032) & (Units) Table 46. Global Chitosan Hemostatic Material Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Chitosan Hemostatic Material Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 48. North America Chitosan Hemostatic Material Sales by Country (2021-2026) & (Units) Table 49. North America Chitosan Hemostatic Material Sales by Country (2027-2032) & (Units) Table 50. Europe Chitosan Hemostatic Material Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 51. Europe Chitosan Hemostatic Material Sales by Country (2021-2026) & (Units) Table 52. Europe Chitosan Hemostatic Material Sales by Country (2027-2032) & (Units) Table 53. Asia Pacific Chitosan Hemostatic Material Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 54. Asia Pacific Chitosan Hemostatic Material Sales by Country (2021-2026) & (Units) Table 55. Asia Pacific Chitosan Hemostatic Material Sales by Country (2027-2032) & (Units) Table 56. South America, Middle East and Africa Chitosan Hemostatic Material Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 57. South America, Middle East and Africa Chitosan Hemostatic Material Sales by Country (2021-2026) & (Units) Table 58. South America, Middle East and Africa Chitosan Hemostatic Material Sales by Country (2027-2032) & (Units) Table 59. Global Chitosan Hemostatic Material Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Chitosan Hemostatic Material Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Chitosan Hemostatic Material Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Chitosan Hemostatic Material Revenue Market Share by Region (2021-2026) Table 63. Global Chitosan Hemostatic Material Revenue Market Share by Region (2027-2032) Table 64. Lanhine Medical Company Information Table 65. Lanhine Medical Business Overview Table 66. Lanhine Medical Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Lanhine Medical Chitosan Hemostatic Material Product Portfolio Table 68. Lanhine Medical Recent Development Table 69. Yancheng Yankang Medical Equipment Company Information Table 70. Yancheng Yankang Medical Equipment Business Overview Table 71. Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Product Portfolio Table 73. Yancheng Yankang Medical Equipment Recent Development Table 74. Shijiazhuang Yishengtang Medical Product Company Information Table 75. Shijiazhuang Yishengtang Medical Product Business Overview Table 76. Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Product Portfolio Table 78. Shijiazhuang Yishengtang Medical Product Recent Development Table 79. Success Bio-Tech Company Information Table 80. Success Bio-Tech Business Overview Table 81. Success Bio-Tech Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Success Bio-Tech Chitosan Hemostatic Material Product Portfolio Table 83. Success Bio-Tech Recent Development Table 84. Biotemed Company Information Table 85. Biotemed Business Overview Table 86. Biotemed Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Biotemed Chitosan Hemostatic Material Product Portfolio Table 88. Biotemed Recent Development Table 89. Haiyuan Hairun Company Information Table 90. Haiyuan Hairun Business Overview Table 91. Haiyuan Hairun Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Haiyuan Hairun Chitosan Hemostatic Material Product Portfolio Table 93. Haiyuan Hairun Recent Development Table 94. Tricol Biomedical Company Information Table 95. Tricol Biomedical Business Overview Table 96. Tricol Biomedical Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Tricol Biomedical Chitosan Hemostatic Material Product Portfolio Table 98. Tricol Biomedical Recent Development Table 99. Mermaid Medical Company Information Table 100. Mermaid Medical Business Overview Table 101. Mermaid Medical Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Mermaid Medical Chitosan Hemostatic Material Product Portfolio Table 103. Mermaid Medical Recent Development Table 104. MedTrade Products Company Information Table 105. MedTrade Products Business Overview Table 106. MedTrade Products Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. MedTrade Products Chitosan Hemostatic Material Product Portfolio Table 108. MedTrade Products Recent Development Table 109. Medcura Company Information Table 110. Medcura Business Overview Table 111. Medcura Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Medcura Chitosan Hemostatic Material Product Portfolio Table 113. Medcura Recent Development Table 114. Hemostasis Company Information Table 115. Hemostasis Business Overview Table 116. Hemostasis Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Hemostasis Chitosan Hemostatic Material Product Portfolio Table 118. Hemostasis Recent Development Table 119. Hemoflex Company Information Table 120. Hemoflex Business Overview Table 121. Hemoflex Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Hemoflex Chitosan Hemostatic Material Product Portfolio Table 123. Hemoflex Recent Development Table 124. BioPharm Med Company Information Table 125. BioPharm Med Business Overview Table 126. BioPharm Med Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. BioPharm Med Chitosan Hemostatic Material Product Portfolio Table 128. BioPharm Med Recent Development Table 129. Anscare Company Information Table 130. Anscare Business Overview Table 131. Anscare Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Anscare Chitosan Hemostatic Material Product Portfolio Table 133. Anscare Recent Development Table 134. Advamedica Company Information Table 135. Advamedica Business Overview Table 136. Advamedica Chitosan Hemostatic Material Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Advamedica Chitosan Hemostatic Material Product Portfolio Table 138. Advamedica Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Chitosan Hemostatic Material Distributors List Table 142. Chitosan Hemostatic Material Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Chitosan Hemostatic Material Product Image Figure 2. Global Chitosan Hemostatic Material Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chitosan Hemostatic Material Market Size (2021-2032) & (US$ Million) Figure 4. Global Chitosan Hemostatic Material Sales (2021-2032) & (Units) Figure 5. Global Chitosan Hemostatic Material Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Chitosan Hemostatic Material Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hemostatic Powder Image Figure 9. Hemostatic Sponge Image Figure 10. Hemostatic Gauze Image Figure 11. Others Image Figure 12. Global Chitosan Hemostatic Material Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Chitosan Hemostatic Material Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Chitosan Hemostatic Material Sales Market Share by Type (2021-2032) Figure 15. Global Chitosan Hemostatic Material Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 16. Global Chitosan Hemostatic Material Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Chitosan Hemostatic Material Revenue Market Share by Type (2021-2032) Figure 18. Surgery Image Figure 19. First Aid Image Figure 20. Global Chitosan Hemostatic Material Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Chitosan Hemostatic Material Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Chitosan Hemostatic Material Sales Market Share by Application (2021-2032) Figure 23. Global Chitosan Hemostatic Material Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 24. Global Chitosan Hemostatic Material Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Chitosan Hemostatic Material Revenue Market Share by Application (2021-2032) Figure 26. North America Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 27. North America Chitosan Hemostatic Material Sales Market Share by Country (2021-2032) Figure 28. U.S. Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 29. Canada Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 30. Mexico Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 31. Europe Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 32. Europe Chitosan Hemostatic Material Sales Market Share by Country (2021-2032) Figure 33. Germany Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 34. France Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 35. U.K. Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 36. Italy Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 37. Netherlands Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 38. Asia Pacific Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 39. Asia Pacific Chitosan Hemostatic Material Sales Market Share by Country (2021-2032) Figure 40. China Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 41. Japan Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 42. South Korea Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 43. Southeast Asia Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 44. India Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 45. Australia Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 46. South America, Middle East and Africa Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 47. South America, Middle East and Africa Chitosan Hemostatic Material Sales Market Share by Country (2021-2032) Figure 48. Brazil Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 49. South Africa Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 50. Saudi Arabia Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 51. Turkey Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 52. Argentina Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 53. UAE Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 54. Egypt Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 55. Chile Chitosan Hemostatic Material Sales and Growth Rate (2021-2032) & (Units) Figure 56. Global Chitosan Hemostatic Material Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Chitosan Hemostatic Material Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Chitosan Hemostatic Material Revenue (2021-2032) & (US$ Million) Figure 59. North America Chitosan Hemostatic Material Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Chitosan Hemostatic Material Revenue (2021-2032) & (US$ Million) Figure 61. Europe Chitosan Hemostatic Material Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Chitosan Hemostatic Material Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Chitosan Hemostatic Material Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Chitosan Hemostatic Material Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Chitosan Hemostatic Material Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Chitosan Hemostatic Material Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Chitosan Hemostatic Material Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Hemostatic Powder
  • Hemostatic Sponge
  • Hemostatic Gauze
  • Others
Applications
  • Surgery
  • First Aid
Companies covered
  • Lanhine Medical
  • Yancheng Yankang Medical Equipment
  • Shijiazhuang Yishengtang Medical Product
  • Success Bio-Tech
  • Biotemed
  • Haiyuan Hairun
  • Tricol Biomedical
  • Mermaid Medical
  • MedTrade Products
  • Medcura
  • Hemostasis
  • Hemoflex
  • BioPharm Med
  • Anscare
  • Advamedica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chitosan Hemostatic Material Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chitosan Hemostatic Material Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Chitosan Hemostatic Material Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Chitosan Hemostatic Material Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Chitosan Hemostatic Material Market Dynamics
  1. 2.1 Chitosan Hemostatic Material Industry Trends
  2. 2.2 Chitosan Hemostatic Material Industry Drivers
  3. 2.3 Chitosan Hemostatic Material Industry Opportunities and Challenges
  4. 2.4 Chitosan Hemostatic Material Industry Restraints
3 Chitosan Hemostatic Material Market by Manufacturers
  1. 3.1 Global Chitosan Hemostatic Material Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Chitosan Hemostatic Material Sales by Manufacturers (2021-2026)
  3. 3.3 Global Chitosan Hemostatic Material Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Chitosan Hemostatic Material Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chitosan Hemostatic Material Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Chitosan Hemostatic Material Manufacturers, Product Type & Application
  7. 3.7 Global Chitosan Hemostatic Material Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chitosan Hemostatic Material Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chitosan Hemostatic Material Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chitosan Hemostatic Material Tier 1, Tier 2, and Tier 3
4 Chitosan Hemostatic Material Market by Type
  1. 4.1 Chitosan Hemostatic Material Type Introduction
  2. 4.1.1 Hemostatic Powder
  3. 4.1.2 Hemostatic Sponge
  4. 4.1.3 Hemostatic Gauze
  5. 4.1.4 Others
  6. 4.2 Global Chitosan Hemostatic Material Sales by Type
  7. 4.2.1 Global Chitosan Hemostatic Material Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Chitosan Hemostatic Material Sales by Type (2021-2032)
  9. 4.2.3 Global Chitosan Hemostatic Material Sales Market Share by Type (2021-2032)
  10. 4.3 Global Chitosan Hemostatic Material Revenue by Type
  11. 4.3.1 Global Chitosan Hemostatic Material Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Chitosan Hemostatic Material Revenue by Type (2021-2032)
  13. 4.3.3 Global Chitosan Hemostatic Material Revenue Market Share by Type (2021-2032)
5 Chitosan Hemostatic Material Market by Application
  1. 5.1 Chitosan Hemostatic Material Application Introduction
  2. 5.1.1 Surgery
  3. 5.1.2 First Aid
  4. 5.2 Global Chitosan Hemostatic Material Sales by Application
  5. 5.2.1 Global Chitosan Hemostatic Material Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Chitosan Hemostatic Material Sales by Application (2021-2032)
  7. 5.2.3 Global Chitosan Hemostatic Material Sales Market Share by Application (2021-2032)
  8. 5.3 Global Chitosan Hemostatic Material Revenue by Application
  9. 5.3.1 Global Chitosan Hemostatic Material Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Chitosan Hemostatic Material Revenue by Application (2021-2032)
  11. 5.3.3 Global Chitosan Hemostatic Material Revenue Market Share by Application (2021-2032)
6 Global Chitosan Hemostatic Material Sales by Region
  1. 6.1 Global Chitosan Hemostatic Material Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chitosan Hemostatic Material Sales by Region (2021-2032)
  3. 6.2.1 Global Chitosan Hemostatic Material Sales by Region (2021-2026)
  4. 6.2.2 Global Chitosan Hemostatic Material Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chitosan Hemostatic Material Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Chitosan Hemostatic Material Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Chitosan Hemostatic Material Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Chitosan Hemostatic Material Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Chitosan Hemostatic Material Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Chitosan Hemostatic Material Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Chitosan Hemostatic Material Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Chitosan Hemostatic Material Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Chitosan Hemostatic Material Revenue by Region
  1. 7.1 Global Chitosan Hemostatic Material Revenue by Region
  2. 7.1.1 Global Chitosan Hemostatic Material Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Chitosan Hemostatic Material Revenue by Region (2021-2026)
  4. 7.1.3 Global Chitosan Hemostatic Material Revenue by Region (2027-2032)
  5. 7.1.4 Global Chitosan Hemostatic Material Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Chitosan Hemostatic Material Revenue (2021-2032)
  8. 7.2.2 North America Chitosan Hemostatic Material Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Chitosan Hemostatic Material Revenue (2021-2032)
  11. 7.3.2 Europe Chitosan Hemostatic Material Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Chitosan Hemostatic Material Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Chitosan Hemostatic Material Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Chitosan Hemostatic Material Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Chitosan Hemostatic Material Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Lanhine Medical
  2. 8.1.1 Lanhine Medical Company Information
  3. 8.1.2 Lanhine Medical Business Overview
  4. 8.1.3 Lanhine Medical Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lanhine Medical Chitosan Hemostatic Material Product Portfolio
  6. 8.1.5 Lanhine Medical Recent Developments
  7. 8.2 Yancheng Yankang Medical Equipment
  8. 8.2.1 Yancheng Yankang Medical Equipment Company Information
  9. 8.2.2 Yancheng Yankang Medical Equipment Business Overview
  10. 8.2.3 Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Product Portfolio
  12. 8.2.5 Yancheng Yankang Medical Equipment Recent Developments
  13. 8.3 Shijiazhuang Yishengtang Medical Product
  14. 8.3.1 Shijiazhuang Yishengtang Medical Product Company Information
  15. 8.3.2 Shijiazhuang Yishengtang Medical Product Business Overview
  16. 8.3.3 Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Product Portfolio
  18. 8.3.5 Shijiazhuang Yishengtang Medical Product Recent Developments
  19. 8.4 Success Bio-Tech
  20. 8.4.1 Success Bio-Tech Company Information
  21. 8.4.2 Success Bio-Tech Business Overview
  22. 8.4.3 Success Bio-Tech Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Success Bio-Tech Chitosan Hemostatic Material Product Portfolio
  24. 8.4.5 Success Bio-Tech Recent Developments
  25. 8.5 Biotemed
  26. 8.5.1 Biotemed Company Information
  27. 8.5.2 Biotemed Business Overview
  28. 8.5.3 Biotemed Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Biotemed Chitosan Hemostatic Material Product Portfolio
  30. 8.5.5 Biotemed Recent Developments
  31. 8.6 Haiyuan Hairun
  32. 8.6.1 Haiyuan Hairun Company Information
  33. 8.6.2 Haiyuan Hairun Business Overview
  34. 8.6.3 Haiyuan Hairun Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Haiyuan Hairun Chitosan Hemostatic Material Product Portfolio
  36. 8.6.5 Haiyuan Hairun Recent Developments
  37. 8.7 Tricol Biomedical
  38. 8.7.1 Tricol Biomedical Company Information
  39. 8.7.2 Tricol Biomedical Business Overview
  40. 8.7.3 Tricol Biomedical Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Tricol Biomedical Chitosan Hemostatic Material Product Portfolio
  42. 8.7.5 Tricol Biomedical Recent Developments
  43. 8.8 Mermaid Medical
  44. 8.8.1 Mermaid Medical Company Information
  45. 8.8.2 Mermaid Medical Business Overview
  46. 8.8.3 Mermaid Medical Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mermaid Medical Chitosan Hemostatic Material Product Portfolio
  48. 8.8.5 Mermaid Medical Recent Developments
  49. 8.9 MedTrade Products
  50. 8.9.1 MedTrade Products Company Information
  51. 8.9.2 MedTrade Products Business Overview
  52. 8.9.3 MedTrade Products Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MedTrade Products Chitosan Hemostatic Material Product Portfolio
  54. 8.9.5 MedTrade Products Recent Developments
  55. 8.10 Medcura
  56. 8.10.1 Medcura Company Information
  57. 8.10.2 Medcura Business Overview
  58. 8.10.3 Medcura Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Medcura Chitosan Hemostatic Material Product Portfolio
  60. 8.10.5 Medcura Recent Developments
  61. 8.11 Hemostasis
  62. 8.11.1 Hemostasis Company Information
  63. 8.11.2 Hemostasis Business Overview
  64. 8.11.3 Hemostasis Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hemostasis Chitosan Hemostatic Material Product Portfolio
  66. 8.11.5 Hemostasis Recent Developments
  67. 8.12 Hemoflex
  68. 8.12.1 Hemoflex Company Information
  69. 8.12.2 Hemoflex Business Overview
  70. 8.12.3 Hemoflex Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hemoflex Chitosan Hemostatic Material Product Portfolio
  72. 8.12.5 Hemoflex Recent Developments
  73. 8.13 BioPharm Med
  74. 8.13.1 BioPharm Med Company Information
  75. 8.13.2 BioPharm Med Business Overview
  76. 8.13.3 BioPharm Med Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BioPharm Med Chitosan Hemostatic Material Product Portfolio
  78. 8.13.5 BioPharm Med Recent Developments
  79. 8.14 Anscare
  80. 8.14.1 Anscare Company Information
  81. 8.14.2 Anscare Business Overview
  82. 8.14.3 Anscare Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Anscare Chitosan Hemostatic Material Product Portfolio
  84. 8.14.5 Anscare Recent Developments
  85. 8.15 Advamedica
  86. 8.15.1 Advamedica Company Information
  87. 8.15.2 Advamedica Business Overview
  88. 8.15.3 Advamedica Chitosan Hemostatic Material Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Advamedica Chitosan Hemostatic Material Product Portfolio
  90. 8.15.5 Advamedica Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chitosan Hemostatic Material Value Chain Analysis
  2. 9.1.1 Chitosan Hemostatic Material Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chitosan Hemostatic Material Production Mode & Process
  6. 9.2 Chitosan Hemostatic Material Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chitosan Hemostatic Material Distributors
  9. 9.2.3 Chitosan Hemostatic Material Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst